After six injections and 2 weeks of observation, the tumor size after intratumorally injected mRNA-OX40L was significantly smaller than that after intratumorally injected encapsulated non-coding mRNA (p ≤ 0.001; Figure 3). This evidence concerns the gene TNFSF4 and neoplasm.